10x Genomics, Inc. Inventory, Finished Goods, Net of Reserves
10x Genomics, Inc. (TXG) had Inventory, Finished Goods, Net of Reserves of $15.96 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Inventory, Net, Items Net of Reserve Alternative › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryFinishedGoodsNetOfReserves · last filed 2026-08-07
- 2026-06-30: Inventory, Finished Goods, Net of Reserves $15.96M.
- 2026-03-31: Inventory, Finished Goods, Net of Reserves $17.41M.
- 2025-12-31: Inventory, Finished Goods, Net of Reserves $23.18M.
- 2025-09-30: Inventory, Finished Goods, Net of Reserves $19.03M.
| Period end | Inventory, Finished Goods, Net of Reserves |
|---|---|
| 2026-06-30 | $15.96M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $17.41M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $23.18M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $19.03M 10-Q · filed 2025-11-07 |
| 2025-06-30 | $18.80M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $15.29M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $16.74M 10-K · filed 2026-02-13 |
| 2024-09-30 | $28.95M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $24.36M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $23.48M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $17.25M 10-K · filed 2025-02-13 |
| 2023-09-30 | $21.84M 10-Q · filed 2023-11-03 |
| 2023-06-30 | $21.65M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $24.68M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $22.48M 10-K · filed 2024-02-15 |
| 2022-09-30 | $19.05M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $20.51M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $14.72M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $13.96M 10-K · filed 2023-02-16 |
| 2021-09-30 | $12.40M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $12.40M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $12.01M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $10.72M 10-K · filed 2022-02-18 |
| 2020-09-30 | $8.91M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $7.18M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $5.69M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $4.84M 10-K · filed 2021-02-26 |
| 2019-09-30 | $4.42M 10-Q · filed 2019-11-12 |
| 2018-12-31 | $2.96M 10-K · filed 2020-02-27 |